Zevia PBC (Class A) (ZVIA) Options Positioning, Max Pain & Unusual Sweeps

Per the Roarable RQD rating, ZVIA scores 22 out of 100, a letter grade of E, with the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars, the Fundamental Cash Engine scores 2 of 20 (ROIC -35%; FCF yield -5.27%), indicating the weakest cash-generation profile in the framework. Whale/13F Flow scores 5 of 20, reflecting institutional accumulation and options positioning that the rating treats as weak support. Insider Conviction scores 3 of 20 based on SEC Form 4 and Congressional PTR cluster flow. Macro Regime Fit scores 4 of 20 with a Beta of 1.0 and sector sensitivity noted. Forensic Balance Sheet scores 8 of 20, citing an Altman Z of 1.64, a Piotroski F of 4/9, and Debt/Equity of 0.5.

For a prospective investor, the rating's message is that the company's operating economics, not its balance sheet alone, drive the low score. Negative ROIC and negative free cash flow yield mean the business is currently not converting capital into returns. Potential upside drivers would require a visible turn in operating margin and free cash flow, which the source data does not yet show. Valuation tradeoffs are difficult to assess because P/E, EV/EBITDA, and EPS are not available in source data, so the stock cannot be benchmarked on earnings. The Altman Z of 1.64 and Piotroski F of 4/9 sit in the zone the rating treats as financially stressed, making balance sheet resilience a key monitoring item. This is an educational summary of the rating's components, not personalized financial advice.

Zevia PBC (Class A) is a NYSE-listed issuer in the Consumer Staples sector, operating within the Beverages (Production/Distribution) industry. Per the profile, the company is classified at a market capitalization of $0.1B. The source data does not describe its specific products, customer base, or revenue model beyond the sector and industry classification. Not available in source data for further business detail.

Per the SEC financials, revenue moved from $166.4M in FY 2023 to $155.0M in FY 2024 before rising to $161.3M in FY 2025, while operating losses narrowed from $-28.9M to $-11.8M over the same span. Market data shows a gross margin of 48%, an operating margin of -7.3%, and a net margin of -6.2%, with ROIC at -35%. The Altman Z-Score is 1.64 and the Piotroski F-Score is 4/9 per the Roarable RQD rating. Debt/Equity is reported at 0.5, and cash was $25.4M at FY 2025 per the SEC financials.

Per the recent news feed, the most significant positive catalysts are a $20 Million Growth Equity Investment announced via Business Wire (CATALYST, GREEN) and a $15 Million raise from Bubble Holdings, with up to $5 Million more available, reported by TradingView (CATALYST, GREEN). Other items are market-wire coverage: a Q2 2026 earnings call transcript (Benzinga), a planned 4:30 p.m. ET call on Nov. 4 to discuss third-quarter results (Stock Titan), an estimates report (TradingView), and a penny-stock watchlist mention (Simply Wall St), all rated YELLOW. The Butterfly Supply-Chain Graph contains no supply-chain links or proprietary signals. Risk watch items include the upcoming third-quarter results call and continued negative operating margin.

• What are the terms and dilution impact of the $20 Million growth equity investment and the Bubble Holdings raise?
• What are the reported EPS, P/E, and EV/EBITDA figures, since these are absent from the source data?
• Does the debt balance (reported as N/A) materially affect the Debt/Equity reading of 0.5?
• What are the drivers behind the revenue recovery from $155.0M to $161.3M, and when might operating losses turn positive?
• What do third-quarter results reveal about the trajectory of operating margin and free cash flow?